Anheuser-Busch InBev stock holds gains as Q2 2026 revenue rises and plant sale reshapes US footprint
Published on 09/04/2026 at 19:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Anheuser-Busch InBev stock (ISIN BE0974293251) has maintained a firm level after recent gains, supported by solid revenue growth in Q2 2026 and a steady full-year outlook, while a planned sale of a former brewery site in New Hampshire highlighted ongoing portfolio adjustments as of September 4, 2026.
Q2 2026 figures underpin valuation
According to analyst data compiled by Yahoo Finance, Anheuser-Busch InBev generated revenue of 16.66 billion USD in Q2 2026, with earnings of 3.75 billion USD and a profit margin of 22.52 percent in the quarter.
Consensus figures on the same page show that analysts had expected Q2 2026 revenue of around 16.23 billion USD for the brewer, meaning the reported 16.66 billion USD came in about 2.6 percent above the average estimate for the period.
Analyst outlook and year-to-date performance
The same analyst overview indicates that for the full year 2026, the average revenue estimate stands at 64.69 billion USD, while the current year 2027 estimate is 67.28 billion USD, signaling that analysts see Anheuser-Busch InBev growing its top line by roughly 4.0 percent from 2026 to 2027.
In the Brussels listing context referenced by the ABI.BR overview on Yahoo Finance, Anheuser-Busch InBev shares most recently closed around 67.72 USD equivalent on September 2, 2026, which places the stock at a level supported by the Q2 2026 beat relative to consensus.
Further information on Anheuser-Busch InBev stock
Investors can find more detailed corporate news, regulatory disclosures and price-sensitive information on Anheuser-Busch InBev shares via the issuer overview and stock-specific topic page.
US footprint changes with New Hampshire plant sale
As reported by The Boston Globe on September 3, 2026, a former Anheuser-Busch plant in Merrimack, New Hampshire, with nearly 700,000 square feet of facility space, has been sold to United Therapeutics, following the brewer’s decision announced in December to close the site and put it up for sale.
The transaction removes a large production site from Anheuser-Busch InBev’s US brewery footprint, while potentially reducing fixed costs and freeing capital that can be redirected toward higher-growth markets and brands.
Flagship brand Budweiser remains central
A key product for Anheuser-Busch InBev is Budweiser, the flagship lager that remains one of the most widely recognized beer brands globally and contributes significantly to the group’s volumes and brand portfolio strength.
Stock level and investor perspective
In the Brussels market, Anheuser-Busch InBev shares recently traded close to 67.72 USD equivalent as of September 2, 2026, reflecting a valuation that now prices in the Q2 2026 revenue beat and the expectation of moderate top-line growth into 2027.
Anheuser-Busch InBev at a glance
- Company: Anheuser-Busch InBev SA/NV
- ISIN: BE0974293251
- Ticker: ABI
- Trading venue: Euronext Brussels
- Price (as of September 2, 2026): 67.72 USD equivalent
- Sector / Industry: Consumer Staples / Beverages
- Index membership: BEL 20
